menu search

Xencor to present preclinical data from xmab® cytokine programs at the american association for cancer research (aacr) annual meeting 2022

MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical comp...

March 8, 2022, 4:31 pm

Regeneron, biontech to test experimental combination therapy for lung cancer

BioNTech SE BNTX, -1.36% and Regeneron pharmaceuticals Inc. REGN, -0.58% said they plan to test an expe...

March 8, 2022, 9:16 am

Diamedica therapeutics to report fourth quarter 2021 financial results and provide a business update march 15, 2022

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical...

March 8, 2022, 8:13 am

Inhibikase therapeutics to present phase 1/1b clinical data at the upcoming ad/pd™ alzheimer's & parkinson's diseases conference

BOSTON and ATLANTA, March 8, 2022 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage ...

March 8, 2022, 8:00 am

Should you invest in the ishares u.s. pharmaceuticals etf (ihe)?

Sector ETF report for IHE...

March 8, 2022, 7:32 am

Eagle pharmaceuticals, inc. (egrx) ceo scott tarriff on q4 2021 results - earnings call transcript

Eagle pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2021 Results - Earnings Call Transcript...

March 7, 2022, 2:02 pm

Eagle pharmaceuticals, inc. (egrx) ceo scott tarriff on q4 2021 results - earnings call transcript

Eagle pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2021 Results - Earnings Call Transcript...

March 7, 2022, 2:02 pm

Eagle pharmaceuticals, inc. (egrx) ceo scott tarriff on q4 2021 results - earnings call transcript

Eagle pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2021 Results - Earnings Call Transcript...

March 7, 2022, 2:02 pm

Taysha gene therapies gets a 'thumbs up'

Shares of biopharmaceutical concern Taysha Gene Therapies, Inc. (TSHA) have lost over 70% of their valu...

March 7, 2022, 1:50 pm

Taysha gene therapies gets a 'thumbs up'

Shares of biopharmaceutical concern Taysha Gene Therapies, Inc. (TSHA) have lost over 70% of their valu...

March 7, 2022, 1:50 pm

Taysha gene therapies gets a 'thumbs up'

Shares of biopharmaceutical concern Taysha Gene Therapies, Inc. (TSHA) have lost over 70% of their valu...

March 7, 2022, 1:50 pm

Eagle pharmaceuticals (egrx) lags q4 earnings and revenue estimates

Eagle pharmaceuticals (EGRX) delivered earnings and revenue surprises of -2.30% and 10.57%, respectivel...

March 7, 2022, 9:45 am

Eagle pharmaceuticals (egrx) lags q4 earnings and revenue estimates

Eagle pharmaceuticals (EGRX) delivered earnings and revenue surprises of -2.30% and 10.57%, respectivel...

March 7, 2022, 9:45 am

Eagle pharmaceuticals (egrx) lags q4 earnings and revenue estimates

Eagle pharmaceuticals (EGRX) delivered earnings and revenue surprises of -2.30% and 10.57%, respectivel...

March 7, 2022, 9:45 am

Ventyx biosciences to participate in the barclays global healthcare conference

ENCINITAS, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx” or the “Company”), a clinical-stage bi...

March 7, 2022, 8:00 am

Ventyx biosciences to participate in the barclays global healthcare conference

ENCINITAS, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx” or the “Company”), a clinical-stage bi...

March 7, 2022, 8:00 am

Ventyx biosciences to participate in the barclays global healthcare conference

ENCINITAS, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx” or the “Company”), a clinical-stage bi...

March 7, 2022, 8:00 am

Ani pharmaceuticals to discuss fourth quarter and full year 2021 financial results on march 15, 2022

BAUDETTE, Minn.--(BUSINESS WIRE)--ANI pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: A...

March 7, 2022, 6:50 am

Ani pharmaceuticals to discuss fourth quarter and full year 2021 financial results on march 15, 2022

BAUDETTE, Minn.--(BUSINESS WIRE)--ANI pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: A...

March 7, 2022, 6:50 am

Ani pharmaceuticals to discuss fourth quarter and full year 2021 financial results on march 15, 2022

BAUDETTE, Minn.--(BUSINESS WIRE)--ANI pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: A...

March 7, 2022, 6:50 am


Search within

Pages Search Results: